Related Experiment Video
Updated: Aug 16, 2026

Multi-parameter Measurement of the Permeability Transition Pore Opening in Isolated Mouse Heart Mitochondria
Published on: September 7, 2012
[Study of mithochondrial permeability transition pore in the development of myocardial and vascular contractility
Abstract:
In experiments on the isolated myocardial and vascular preparations the role of the mithochondrial permiability transition pore (mPTP) in the development of reperfusion injury was investigated. Co-perfusion of the previously activated myocardial trabecula (MT) and arterial rings (AR) by solution collected during the first 5 min of isolated heart reperfusion, caused a sharp and significant decrease of tonic tension of both isolated preparations. Besides the significant inhibition of the MT and AR reactions after electrical stimulation, modulation of AR reaction by the influence of MT is also registered. The solution collected at first minutes of heart reperfusion, preserve a dilation property within 24 hours of storage at room temperature. Preliminary perfusion of MT and AR with methylen blue (MB, 10(-4) M/l) or the addition to the solution dithiothreitol (DTT, 2 x 10(-5) M/l) and diethyl maleate (DEM, 2 x 10(-5) M/l) resulted in an almost complete inhibition of this dilatation influence on the isolated preparations. The data received testify that the solution comprise a NO-containing substance, possible nitrosoglutation. Pre-incubation (2 min) MT in a solution with mPTP activator phenylarsine oxide (PAO, 10(-5) M/l) and subsequent reperfusion with a control solution resulted in deep and irreversible decrease of tonic tension and inhibition of contractility of both isolated preparations. The received data are qualitatively similar to results described above. Our data and results received in additional experiments on isolated mitochondria allow us to assert that solution flowing from the ischemized heart contains the stable mitochondrial factor (SMF) with a significant dilatation property. An addition of MB and DEM in the reperfusion solution abrogated its dilation influence. Co-perfusion (10 min) of the injured MT and AR by the solution with nitrosoglutation (10 (-5) M/l) restored normal contractility of the isolated preparations and modulation of the AR reaction by the influence of MT. It once again confirms the presence of an NO-containing substance in the SMF content. Thus, the mPTP activation plays the key role in the development ofmyocardial reperfusion injury and results in release of SMF, which can be the basic agent of paracrine regulation of myocardial contractility, coronary and peripheral vessels tone.
Insights
Mitochondrial permeability transition pore (mPTP) activation is key in reperfusion injury, releasing a stable mitochondrial factor (SMF) that affects contractility and vascular tone. Inhibiting mPTP or using nitrosoglutathione can mitigate these effects.
Area of Science:
- Cardiovascular Biology
- Mitochondrial Physiology
- Cellular Injury Mechanisms
Background:
- Reperfusion injury significantly impacts myocardial and vascular function.
- The role of mitochondrial permeability transition pore (mPTP) in this process is not fully elucidated.
- Identifying factors released during reperfusion is crucial for understanding injury mechanisms.
Purpose of the Study:
- To investigate the role of mPTP in myocardial reperfusion injury.
- To identify and characterize factors released from the ischemic heart during reperfusion.
- To explore potential therapeutic interventions targeting mPTP and released factors.
Main Methods:
- Experiments on isolated myocardial trabeculae (MT) and arterial rings (AR).
- Co-perfusion studies using solutions collected during early heart reperfusion.
- Treatment with mPTP modulators (PAO, MB), antioxidants (DTT), and NO-containing substances (nitrosoglutathione).
- Assessment of tonic tension, electrical stimulation responses, and contractility.
Main Results:
- Reperfusion solution significantly decreased tonic tension and inhibited electrical stimulation responses in MT and AR.
- This effect was mediated by a stable mitochondrial factor (SMF) with vasodilatory properties, identified as an NO-containing substance.
- Inhibition of mPTP (using MB) or addition of antioxidants (DEM) abrogated the SMF's dilatory influence.
- Pre-incubation with an mPTP activator (PAO) mimicked reperfusion injury.
- Nitrosoglutathione restored normal contractility and vascular modulation.
Conclusions:
- mPTP activation is central to myocardial reperfusion injury, leading to SMF release.
- SMF, likely containing NO, acts as a paracrine regulator of myocardial contractility and vascular tone.
- Targeting mPTP and SMF offers a potential therapeutic strategy for reperfusion injury.
More Related Videos
07:35Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
Published on: June 1, 2022
10:53Analysis of the Mitochondrial Density and Longitudinal Distribution in Rat Live-Skeletal Muscle Fibers by Confocal Microscopy
Published on: December 1, 2023
Related Concept Videos
Mitochondrial Membranes
The Inner Mitochondrial Membrane
Pathophysiology of Cardiac Performance
Myocarditis I: Introduction